Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830628) titled 'Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer' on Sept. 15.

Study Type: Observational

Primary Sponsor: CHA University

Condition: Biliary Tract Cancer (BTC)

Intervention: Other: Bile Sampling for ctDNA Analysis

Recruitment Status: Not recruiting

Date of First Enrollment: September 1, 2026

Target Sample Size: 100

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07830628

Published by HT Digital Content Services with permission from Health Daily Digest....